The U.S. Securities and Exchange Commission has approved the first 3x leveraged Bitcoin and Ethereum exchange-traded funds available to American investors. These products offer three times the daily exposure of the underlying crypto assets, making them among the most aggressive crypto investment products ever cleared for U.S. markets.
What the SEC Approved: The First U.S. 3x BTC and ETH ETFs
Until now, no U.S.-listed ETF offered 3x leveraged exposure specifically to Bitcoin (BTC) or Ethereum (ETH) as standalone products. That changed with this SEC approval, first reported by CoinGape. The products track the two largest cryptocurrencies by market value, giving investors a way to access amplified crypto exposure through a regulated brokerage account, without holding the coins directly. For related coverage, see IMF Approves $138M for El Salvador After Bitcoin Rule Waiver.
The issuer behind the products is REX Shares, a firm that specializes in alternative and leveraged ETFs. Filing records for these products are accessible through the SEC EDGAR search system. More background on REX Shares’ product lineup is available at rexshares.com.
This approval builds on the SEC’s earlier decision to greenlight 3x Bitcoin and Ether futures products on Cboe BZX, which laid regulatory groundwork for leveraged crypto ETF structures in the U.S. For related coverage, see IMF Approves $139M El Salvador Payout After Bitcoin Waiver.
How the 3x ETFs Track Bitcoin and Ethereum
A 3x leveraged ETF aims to deliver three times the daily return of its benchmark. If Bitcoin rises 5% in a single day, a 3x Bitcoin ETF targets a 15% gain that same day. The reverse is also true: a 5% drop in Bitcoin would translate to roughly a 15% loss in the ETF.
There are separate products for Bitcoin and Ethereum, meaning investors can choose exposure to one or both assets. The specific rebalancing mechanics, expense ratios, and ticker symbols were not detailed in the available reporting, so investors should review the official fund documentation before making any decisions.
Leveraged ETFs are designed for short-term trading, not long-term holding. Because they reset their leverage daily, returns over multiple days can diverge significantly from simply multiplying the underlying asset’s performance over that same period.
Why the Approval Matters for Crypto ETF Investors
Being the first of their kind in the U.S. makes these products a notable milestone. Until now, investors wanting amplified crypto exposure through a brokerage account had limited options. These ETFs bring a tool previously common in equity markets into the crypto space under SEC oversight.
U.S. spot Bitcoin ETFs have already drawn substantial investor interest since their own approval, with products posting some of their strongest sustained inflows since the prior bull market. The 3x products enter a market already familiar with crypto ETF structures, but they represent a meaningfully higher risk profile.
The amplified upside is real, but so is the amplified downside. A 33% drop in Bitcoin in a single session would wipe out nearly the entire value of a 3x Bitcoin ETF. These instruments are designed for experienced traders with a short time horizon, not investors looking to hold crypto for years. Bitcoin’s growing presence in regulated custody services signals that traditional finance is building more infrastructure around these assets, but leveraged ETFs remain a specialist tool within that broader trend.
Anyone considering these products should read the prospectus carefully, understand how daily leverage reset works, and confirm the product’s fees and structure directly with the fund issuer before investing.
Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency and digital asset markets carry significant risk. Always research thoroughly before making decisions.
Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency and digital asset markets carry significant risk. Always do your own research before making decisions.
